As the metabolomics field gears up, scientists are clearing the path by working to establish standards, protocols, and quality controls.

BIOINFORMATICS

BOOK REVIEWS

RNAi teams up with pathway analysis to give rise to a high-throughput, large-scale approach to tracking genes. A look at pathway analysis and some of the latest publications in the field.

SEQUENCING

PROTEOMICS

NEWS IN BRIEF

MICROARRAYS

NEWS SPOTLIGHT

LETTER FROM THE EDITOR

Genome sequencing has shown us just how little we actually know about the genes we’re finding. Not to be outdone, scientists have commandeered a variety of technological approaches and are working to elucidate the function of all those mystery genes.

RNA INTERFERENCE

The Omics! Omics! blog wonders what "Sanger sequencing" really means.

Science this week tackles testing mathematics and science students, the Giardia genome, and the mitochondrial genome of the Siberian mammoth.

A blogger posts about what makes him a happy bioinformaticist.

An interview with James Watson reveals some uncanny insights.

NEWSBRIEF

The NEUROscreen project gives the company a bit of a financial boost, but more importantly, serves as an important step in proving the value of its stem cell platform as a drug-discovery tool, according to a company official.

Tokarz said that the limitation of doing everything in microtiter plates is that the rates of fluid exchange are very slow and that in the future, the need will arise for fast perfusion, because the neutral buffer around cells will need to be switched quickly.

The agreement follows a string of purchases that Agilent has made over the past few years to shore up its informatics offering. Now it appears that the company is moving away from this acquisition strategy in favor of a partnership model for serving its customers’ informatics needs.

InforSense and GenomeQuest To Integrate and Sequence Search Software   InforSense and GenomeQuest will integrate technologies for better probing of data and sharing of work processes across research domains.

MPI investigators found that multiparametric HCA is important to clearly identify the “on-target” phenotype and that multiple siRNAs targeting the same mRNA will provide more information than repetitions of siRNA experiments

Cadus Technologies of New York City has been awarded US Patent 7,273,747, “Cell having amplified signal transduction pathway responses and uses therefore.”   The inventors listed on the abstract John Manfredi,

Genedata this week announced the release of its Screener Version 5.0, a data analysis and management solution for screen-to-lead research.   The company said that Screener 5.0 combines enterprise assay data management with pr

NEWSBRIEF